Coris Bioconcept

Executive Summary

Coris BioConcept is a Belgian SME with over 25 years of experience in developing and manufacturing rapid diagnostic tests for infectious diseases, with a focus on antibiotic resistance, bacteria, parasites, and viruses. The company leverages lateral flow, electrochemistry, and RT-LAMP technologies to deliver point-of-care and laboratory solutions. While established, Coris operates in a competitive diagnostics market and has not disclosed recent funding or valuation, suggesting a lean, self-sustaining profile. Its long track record indicates resilience, but growth may depend on expanding into new segments or securing strategic partnerships.

Upcoming Catalysts (preview)

• Q2 2026Launch of new multiplex RT-LAMP panel for respiratory pathogens70% success
• Q3 2026CE-IVDR certification for existing lateral flow product line80% success
• Q4 2026Strategic distribution partnership for African market expansion60% success